By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SR Pharma PLC 

Centre Point, 26th Floor
103, New Oxford Street
London  England  WC1A 1DD  United Kingdom
Phone: 44-0-20-7307-1620 Fax: 44-0-20-7307-1680



Company News
SR Pharma PLC (SPA.L) Completes Name Change to Silence Therapeutics plc 5/4/2007 11:16:10 AM
UK Biotech SR Pharma PLC (SPA.L) Swaps Name to Ride RNAi Wave 4/2/2007 3:14:03 PM
SR Pharma PLC (SPA.L) Preliminary Results for the Year Ended 31 December 2006 3/30/2007 1:26:16 PM
SR Pharma PLC (SPA.L) Announces Start Of Phase I Trial With Novel RNAi Therapeutic RTP-801i In Age-Related Macular Degeneration (AMD) 2/5/2007 11:09:37 AM
SR Pharma PLC (SPA.L) To Conduct Full Toxicological Evaluation Of RNAi Candidate Atu027 1/31/2007 4:22:12 PM
SR Pharma PLC (SPA.L) Granted Core RNAi Patent By European Patent Office 1/3/2007 6:27:17 PM
SR Pharma PLC (SPA.L) Congratulates Andrew Fire And Craig Mello On Receiving The Nobel Prize In Physiology Or Medicine In 2006 12/11/2006 1:24:19 PM
SR Pharma PLC (SPA.L) Places 20 Mln Shares At 19p/Shr Raising 3.8 Mln Stg 11/8/2006 12:02:30 PM
Pfizer Inc. (PFE) Expands Research Commitment To Ophthalmology Through Licensing Agreement With Quark Biotech, Inc.; Atugen AG Will Receive Payments Up To US$95 Million 9/26/2006 12:06:22 PM
SR Pharma PLC (SPA.L) Gets Encouraging Results In Mice For Pancreatic Cancer Drug 9/14/2006 2:44:19 PM